Navigation Links
What is the role of focal therapy in low-risk prostate cancer?
Date:5/18/2010

May 2010 -- In the July issue of European Urology, the scientific journal of the European Association of Urology (EAU), S. Eggener et al. discussed in a recent study the significance and impact of focal therapy for low-risk cancer patients.

Since the introduction of prostate cancer screening based on prostate-specific antigen (PSA), over-treatment has increased. A significant proportion of patients diagnosed with prostate cancer have well differentiated, low-volume tumours at minimal risk of impacting their quality of life or longevity. The selection of a treatment strategy, among the multitude of options, has enormous implications for individuals and health care systems.

A conceptually appealing option to patients uncomfortable with observational strategies yet highly concerned about the risks of whole-gland treatment is to bridge elements of active surveillance with whole-gland therapy. This hybrid approach, termed focal therapy, aims to eradicate known cancer foci with the highest likelihood of progressing or metastasizing while attempting to diminish collateral damage to the vital structures essential for maintaining normal urinary and sexual function.

Limitations of focal therapy include the inability to stage or grade the cancer(s) accurately, suboptimal imaging capabilities, uncertainty regarding the natural history of untreated cancer foci, challenges with post-treatment monitoring, and the lack of quality-of-life data compared with alternative treatment strategies.

The aim of the present study was to review the rationale, patient selection criteria, diagnostic imaging, biopsy schemes, and treatment modalities available for the focal therapy of localized prostate cancer.

A National Center for Biotechnology Information PubMed search (www.pubmed.gov) was performed from 1995 to 2009 using medical subject headings ''focal therapy'' or ''ablative'' and ''prostate cancer'.' Additional articles were extracted based on recommendations from an expert panel of authors.

One of the conclusions of the study is that focal therapy for prostate cancer is a promising and emerging treatment strategy for men with a low risk of cancer progression or metastasis. Evaluation in formal prospective clinical trials is essential before this new strategy is accepted in clinical practice.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Related medicine news :

1. UV LED therapy shows promising results in preventing focal seizures
2. Well-tolerated radiotherapy provides longer life to patients with recurrent brain cancer
3. Combination therapy targets stubborn leukemia stem cells
4. Study demonstrates art therapys effectiveness in pediatric asthma
5. Physical Therapy Online Continuing Education Courses Undergo an Inevitable Evolution
6. Complimentary Injury Screenings Available at All AthletiCo Physical and Occupational Therapy Centers
7. Phase II study of an oral therapy for Gaucher disease yields positive results
8. Magnet Therapy May Ease Hard-to-Treat Depression
9. FDA Reviews Side Effects From Prostate Cancer Therapy
10. Finding cancer cold spots can help minimize radiotherapy side-effects
11. Dana-Farber/Provenge: Approval of prostate cancer immunotherapy-new era of cancer treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... 01, 2017 , ... Expert on international living and leading a healthy lifestyle, ... , Time & Go app is the ultimate strategic compass that helps users to ... methods enable people to work smarter, not harder, that's why Time & Go app ...
(Date:3/1/2017)... ... 01, 2017 , ... March 2017 – All year round the treadmill represents ... stop training to brave the cold weather, snow or ice. Treadmill running poses special ... help protect these vulnerable joints, says orthopaedic surgeon Kevin D. Plancher, MD, founder of ...
(Date:3/1/2017)... ... March 01, 2017 , ... “McFarnia”: a suspenseful tale of a father who ... life and mysterious disappearance. “McFarnia” is the creation of published author Tony Pierzchala, a ... currently serves as a Chaplain with Transport for Christ at a truck stop in ...
(Date:3/1/2017)... ... , ... “Letter of Love”: a tale of young love and war. ““Letter ... Civil War in El Salvador, wife, mother, and co-founder of a Christian College. , ... to serve in very poor communities, and I study psychology. I lived the civil ...
(Date:3/1/2017)... ... March 01, 2017 , ... “The Affair is Over Now Go ... emotional upheaval of an extramarital affair. “The Affair is Over Now Go Live Your ... former lay pastor who has dedicated her professional life to teaching and writing about ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... India and PRINCETON, N.J. ... Industries Ltd (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: ... subsidiaries or associate companies) today announced that several ... clinical trials (reSURFACE 1 and 2) of tildrakizumab, ... treatment of moderate-to-severe plaque psoriasis, will be presented ...
(Date:3/1/2017)... March 1, 2017  The Board of Directors of ... Turfe as the new CEO and Chairman of ... of long-time Chairman and CEO William R. Cobb ... nationwide search, and brings a wealth of experience in ... "In a pool of incredibly qualified ...
(Date:3/1/2017)... March 1, 2017 Lo stesso sistema sara, visibile nello ... Paramed Medical Systems sta installando la settima unità MROpen in ... nel nuovo centro dell,European Scanning Center (ESC) a Cardiff. ESC attualmente gestisce altri ... Manchester. Continue Reading ... ...
Breaking Medicine Technology: